Capecitabine and oxaliplatin for advanced esophagogastric cancer

N Engl J Med. 2008 May 1;358(18):1965; author reply 1965. doi: 10.1056/NEJMc080178.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / economics
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Capecitabine
  • Cisplatin / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / economics
  • Drug Costs
  • Esophageal Neoplasms / drug therapy*
  • Fluorouracil / administration & dosage
  • Fluorouracil / analogs & derivatives*
  • Fluorouracil / economics
  • Humans
  • Organoplatinum Compounds / administration & dosage*
  • Organoplatinum Compounds / adverse effects
  • Organoplatinum Compounds / economics
  • Oxaliplatin

Substances

  • Organoplatinum Compounds
  • Oxaliplatin
  • Deoxycytidine
  • Capecitabine
  • Cisplatin
  • Fluorouracil